Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exendin agonist analogs to treat diabetes

Exendin agonist analogs to treat diabetes

US Patent 7700549 · Granted Apr 20, 2010

Estimated economic value: $30,100,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucagon-receptor selective polypeptides and methods of use thereof2023
Methods comprising continuous administration of exenatide and co-administration 2023
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Glucagon-receptor selective polypeptides and methods of use thereof2022
Detection of rare sequence variants, methods and compositions therefor2021
Methods comprising continuous administration of a GLP-1 receptor agonist and co-2020
Bile acid recycling inhibitors for treatment of obesity and diabetes2020
Glucagon-receptor selective polypeptides and methods of use thereof2019
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2019
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2019
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics2018
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics2016